G 3725
Pill imprint G 3725 has been identified as Glyburide 1.25 mg.
Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy.
Glyburide 1.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Glyburide Images
- Imprint:
-
G 3725
- Strength:
- 1.25 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
magnesium stearate
microcrystalline cellulose
sodium alginate
magnesium silicate
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Greenstone Limited
- National Drug Code (NDC):
- 59762-3725
Advertisement
More GlyBURIDE resources
- Glyburide
- Glyburide (Wolters Kluwer)
- Glyburide Tablets (Micronized) (Wolters Kluwer)
- glyburide (Cerner Multum)
- Euglucon (Micromedex) - Includes Dosage Information
- glyburide (Micromedex) - Includes Dosage Information
- Glyburide (AHFS DI)
- Glyburide Micronized (FDA)
- Glyburide Tablets (FDA)
- Glyburide (Wolters Kluwer)
Search Again
